Overall rank by patents
#37,754
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01D (SEPARATION).
The verdict
Svante holds 7 US patents across 9 technology areas, rank #37,754 of 50,000 tracked assignees.
Svante Inc. has been granted 7 US utility patents between 2021 and 2023, placing Svante Inc. at rank #37,754 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.6 claims per patent with primary concentration in B01D (SEPARATION). As a Foreign Corporation, Svante Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Svante sits between Surround Medical Systems, Inc. (7 patents, rank #37,750) and Swift IP, Llc (7 patents, rank #37,758) - the closest US assignees by grant volume. The composite Innovation Score of 39.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Svante Inc.'s 20.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Svante Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Surround Medical Systems, Inc.
7 patents
Sutter Bay Hospitals
7 patents
Suzhou Cosyland Trading Co., Ltd.
7 patents
Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences
7 patents
Swan Products, LLC
7 patents
Swell Ventures LLC
7 patents
Swift Distribution, Inc.
7 patents
Swift IP, LLC
7 patents
Svante Inc.
7 patents
What this shows Svante holds 7 patents at rank #37,754, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #37,754 in granted patent volume.
Other assignees with the most granted patents in Svante's primary technology class.
Svante's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 42.9% |
| 2022 | 2 | 28.6% |
| 2023 | 2 | 28.6% |
Top 9 of 9 technology areas
Overall rank by patents
#37,754
Across all tracked assignees
39.0 out of 100
How to use this portfolio
Svante's 7 grants land it in the top 39% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.